176 related articles for article (PubMed ID: 8177365)
1. 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding sites in goldfish retina.
Lima L; Schmeer C; Urbina M
Neurochem Res; 1994 Mar; 19(3):249-55. PubMed ID: 8177365
[TBL] [Abstract][Full Text] [Related]
2. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
Herrick-Davis K; Titeler M
J Neurochem; 1988 Feb; 50(2):528-33. PubMed ID: 2961850
[TBL] [Abstract][Full Text] [Related]
3. Further characterization of 5-HT1A receptors in the goldfish retina: role of cyclic AMP in the regulation of the in vitro outgrowth of retinal explants.
Schmeer C; Obregón F; Urbina M; Lima L
Neurochem Res; 2001 Mar; 26(3):213-23. PubMed ID: 11495544
[TBL] [Abstract][Full Text] [Related]
4. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
Emerit MB; Miquel MC; Gozlan H; Hamon M
J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
[TBL] [Abstract][Full Text] [Related]
5. 8-[3H]-hydroxy-2-(di-n-propylamino)tetralin binding sites in blood lymphocytes of rats and the modulation by mitogens and immobilization.
Sempere T; Cedeño N; Urbina M; Lima L
J Neuroimmunol; 2003 May; 138(1-2):8-16. PubMed ID: 12742647
[TBL] [Abstract][Full Text] [Related]
6. [3H]serotonin binding sites in goldfish retinal membranes.
Lima L; Radtke I; Drujan B
Neurochem Res; 1992 Oct; 17(10):991-6. PubMed ID: 1508309
[TBL] [Abstract][Full Text] [Related]
7. [3H]spiroxatrine labels a serotonin1A-like site in the rat hippocampus.
Nelson DL; Monroe PJ; Lambert G; Yamamura HI
Life Sci; 1987 Sep; 41(13):1567-76. PubMed ID: 2957559
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin.
Nénonéné EK; Radja F; Carli M; Grondin L; Reader TA
J Neurochem; 1994 May; 62(5):1822-34. PubMed ID: 8158133
[TBL] [Abstract][Full Text] [Related]
9. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
10. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
[TBL] [Abstract][Full Text] [Related]
11. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
[TBL] [Abstract][Full Text] [Related]
12. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
[TBL] [Abstract][Full Text] [Related]
13. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.
Hashimoto T; Nishino N; Nakai H; Tanaka C
Life Sci; 1991; 48(4):355-63. PubMed ID: 1824956
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and neurochemical effects of the serotonin (5-HT)1A receptor ligand spiroxatrine.
Barrett JE; Hoffmann SM; Olmstead SN; Foust MJ; Harrod C; Weissman BA
Psychopharmacology (Berl); 1989; 97(3):319-25. PubMed ID: 2524083
[TBL] [Abstract][Full Text] [Related]
15. The 5-HT1A receptor probe [3H]8-OH-DPAT labels the 5-HT transporter in human platelets.
Ieni JR; Meyerson LR
Life Sci; 1988; 42(3):311-20. PubMed ID: 2961966
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
Schlegel JR; Peroutka SJ
Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of 5HT1A receptors induces lower lip retraction in the rat.
Berendsen HH; Jenck F; Broekkamp CL
Pharmacol Biochem Behav; 1989 Aug; 33(4):821-7. PubMed ID: 2533357
[TBL] [Abstract][Full Text] [Related]
18. Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues.
Harrington MA; Peroutka SJ
J Neurochem; 1990 Jan; 54(1):294-9. PubMed ID: 2136705
[TBL] [Abstract][Full Text] [Related]
19. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
20. Mg2+ enhances high affinity [3H]8-hydroxy-2-(di-n-propylamino) tetralin binding and guanine nucleotide modulation of serotonin-1a receptors.
DeVinney R; Wang HH
J Recept Signal Transduct Res; 1995 Apr; 15(5):757-71. PubMed ID: 8747885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
